OTCMKTS:MCUJF Medicure (MCUJF) Stock Price, News & Analysis → Are you prepared for a Chinese 'invasion?' (From Behind the Markets) (Ad) Free MCUJF Stock Alerts $0.77 0.00 (0.00%) (As of 06/17/2024 ET) Add Compare Share Share Today's Range$0.77▼$0.7750-Day Range$0.68▼$0.8052-Week Range$0.68▼$1.26VolumeN/AAverage Volume4,365 shsMarket Capitalization$8.05 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Get Medicure alerts: Email Address Ad Behind the MarketsAre you prepared for a Chinese "invasion?"Recently declassified documents show that while the U.S has been distracted in the Middle East... China had been studying our every move... And preparing themselves for not only an armed conflict with the United StatesHere are 4 steps you can take RIGHT NOW >>> About Medicure Stock (OTCMKTS:MCUJF)Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company offers Sodium Nitroprusside injection for the reduction of blood pressure for adult and pediatric patients in hypertensive crisis, as well as for producing controlled hypotension to reduce bleeding during surgery, and for the treatment of acute congestive heart failure. It offers products through retail and mail order pharmacies. The company was incorporated in 1997 and is headquartered in Winnipeg, Canada.Read More MCUJF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MCUJF Stock News HeadlinesMay 28, 2024 | finance.yahoo.comMedicure Reports Financial Results for Quarter Ended March 31, 2024 and Annual General Meeting Director Election ResultsDecember 5, 2023 | finance.yahoo.comMedicure Announces New Partnership Through Its Marley Drug Subsidiary to Provide Brenzavvy(R) as an Affordable Medication for Americans with Type 2 DiabetesNovember 24, 2023 | msn.comMedicure approved to enrol patients in paediatric disease trialNovember 23, 2023 | benzinga.comMedicure Announces FDA Provides Complete Approval to Enroll Patients in Its Pivotal Phase 3 Trial for Treatment of Rare Pediatric DiseaseNovember 21, 2023 | msn.comMedicure GAAP EPS of C$0.01, revenue of C$5MNovember 21, 2023 | finance.yahoo.comMedicure Reports Financial Results for Quarter Ended September 30, 2023October 24, 2023 | finance.yahoo.comMedicure Inc.'s (CVE:MPH) Stock Is Going Strong: Have Financials A Role To Play?October 2, 2023 | theglobeandmail.comMedicure: Top 10 Undervalued Drug Manufacturers Industry Stocks (MPH)August 25, 2023 | theglobeandmail.comClosing Bell: Medicure Inc flat on Thursday (MPH)August 15, 2023 | theglobeandmail.comClosing Bell: Medicure Inc flat on Monday (MPH)July 29, 2023 | theglobeandmail.comClosing Bell: Medicure Inc flat on Friday (MPH)July 29, 2023 | finance.yahoo.comMedicure Reports Financial Results For Quarter Ended June 30, 2023July 24, 2023 | finance.yahoo.comMedicure to Present Financial Results on July 31, 2023 Call at 8:30 AM ET for Quarter Ended June 30, 2023May 26, 2023 | finance.yahoo.comMedicure Reports Financial Results for Quarter Ended March 31, 2023May 24, 2023 | theglobeandmail.comClosing Bell: Medicure Inc down on Tuesday (MPH)May 21, 2023 | finance.yahoo.comPoly Medicure Limited (POLYMED.NS)May 5, 2023 | theglobeandmail.comClosing Bell: Medicure Inc up on Friday (MPH)April 6, 2023 | finance.yahoo.comMedicure Reports Financial Results for Quarter and Year Ended December 31, 2022April 5, 2023 | finance.yahoo.comMedicure To Present Financial Results on April 10, 2023 Call at 8:30 AM ET for Quarter and Year Ended December 31, 2022February 1, 2023 | finance.yahoo.comMEDICURE ANNOUNCES RESIGNATION OF BOARD MEMBER AND GRANT OF STOCK OPTIONSNovember 25, 2022 | seekingalpha.comMedicure Inc. (MCUJF) Q3 2022 Earnings Call TranscriptNovember 24, 2022 | finance.yahoo.comMEDICURE REPORTS FINANCIAL RESULTS FOR QUARTER ENDED SEPTEMBER 30, 2022November 18, 2022 | finance.yahoo.comMEDICURE TO PRESENT FINANCIAL RESULTS ON NOVEMBER 25, 2022 CALL at 8:30 AM ET FOR QUARTER ENDED SEPTEMBER 30, 2022October 19, 2022 | investing.comPoly Medicure Ltd (PLMD)September 26, 2022 | finance.yahoo.comEARLY WARNING NEWS RELEASE - DR. ALBERT D. FRIESEN'S HOLDINGS IN MEDICURE INC.See More Headlines Receive MCUJF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medicure and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/08/2024Today6/18/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolOTCMKTS:MCUJF CUSIPN/A CIK1133519 Webwww.medicure.com Phone(204) 487-7412Fax204-488-9823EmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.08) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-680,000.00 Net Margins-5.25% Pretax Margin-5.10% Return on Equity-5.47% Return on Assets-3.98% Debt Debt-to-Equity Ratio0.01 Current Ratio2.01 Quick Ratio1.59 Sales & Book Value Annual Sales$16.07 million Price / Sales0.50 Cash Flow$0.09 per share Price / Cash Flow8.70 Book Value$1.41 per share Price / Book0.55Miscellaneous Outstanding Shares10,440,000Free Float9,090,000Market Cap$8.05 million OptionableNot Optionable Beta0.91 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesDr. Neil Owens Ph.D.President & COODr. Reuben Saba Ph.D.Vice President of Scientific & Medical AffairsDr. Albert David Friesen Ph.D. (Age 77)Founder, CEO & Chairman of the board Comp: $173.31kMr. Haaris Uddin B.Com.CPA, Chief Financial OfficerKey CompetitorsLisata TherapeuticsNASDAQ:LSTABioVieNASDAQ:BIVIIGC PharmaNYSEAMERICAN:IGCAcasti PharmaNASDAQ:ACSTPalatin TechnologiesNYSEAMERICAN:PTNView All Competitors MCUJF Stock Analysis - Frequently Asked Questions How have MCUJF shares performed in 2024? Medicure's stock was trading at $0.7754 on January 1st, 2024. Since then, MCUJF shares have decreased by 0.5% and is now trading at $0.7715. View the best growth stocks for 2024 here. Are investors shorting Medicure? Medicure saw a increase in short interest in May. As of May 31st, there was short interest totaling 400 shares, an increase of 33.3% from the May 15th total of 300 shares. Based on an average daily volume of 3,900 shares, the short-interest ratio is currently 0.1 days. View Medicure's Short Interest. How were Medicure's earnings last quarter? Medicure Inc. (OTCMKTS:MCUJF) released its quarterly earnings results on Monday, April, 8th. The company reported ($0.10) earnings per share for the quarter. The business earned $3.73 million during the quarter. Medicure had a negative trailing twelve-month return on equity of 5.47% and a negative net margin of 5.25%. How do I buy shares of Medicure? Shares of MCUJF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:MCUJF) was last updated on 6/18/2024 by MarketBeat.com Staff From Our PartnersBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | SponsoredBeta testers blew this thing upThis AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and fi...Prosper Trading Academy | SponsoredRadical change coming — do this NOW to protect yourselfI recently uncovered a way the government could use the next crisis as a pretext to gain more control … and ra...Weiss Ratings | SponsoredUnexpected twist to Trump’s trialUnexpected Twist to Trump's Trial Most folks sense there's more to the Trump trial than meets the eye. B...Stansberry Research | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredInflation Is Robbing You Blind! Here’s How to Fight Back!Quietly, inflation has reduced your purchasing power by 29.4% since 2014. So something that cost $100 in 20...American Alternative | SponsoredElon Musk: THIS will be bigger than TeslaIf you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medicure Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medicure With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.